Related Experiment Videos
A thiol protease inhibitor released from cultured human malignant melanoma cells
Abstract:
A thiol protease inhibitor (TPI) was found in culture media of human malignant melanoma cells (Bowes) at 1.5 to 2.3 units/day/flask (full sheet, 75 sq cm). This amount well exceeded that for cultured nonmalignant cells (human fetal lung fibroblasts). In the intracellular region of the melanoma cells, TPI activity was localized mainly in the cytosol fraction. The difference in specific activities between the intracellular and extracellular TPI and the TPI accumulation in the culture media indicated that cultured melanoma cells release TPI. Partial purification and characterization of the TPI by column chromatography using Sephadex G-150, papain-Sepharose, and Sephadex G-50, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, revealed two distinct TPIs with molecular weights of 56,000 and 9,800 to 10,800. The latter (main) TPI had a high specificity for thiol proteases and was heat stable (60 degrees for 60 min), like previously reported normal human TPIs. The inhibitor, however, differed from normal human TPIs in that it had a lower molecular weight than any normal TPI, was unable to inhibit bromelain, and exhibited a mosaic pattern; namely, the low-molecular-weight TPI resembled liver-type TPI but the pH stability curve resembled serum-type TPI. The thiol protease, cathepsin B, was not detected in culture media of this human melanoma cell line.
Insights
Human malignant melanoma cells release thiol protease inhibitors (TPIs) into culture media, exceeding levels found in nonmalignant cells. These melanoma-derived TPIs exhibit unique characteristics compared to normal human TPIs.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Thiol protease inhibitors (TPIs) play crucial roles in cellular regulation.
- Understanding TPIs in cancer cells is vital for developing targeted therapies.
- Malignant melanoma cells are known to secrete various factors that influence their microenvironment.
Purpose of the Study:
- To investigate the presence and characteristics of thiol protease inhibitors (TPIs) secreted by human malignant melanoma cells.
- To compare the TPIs from melanoma cells with those from nonmalignant cells.
- To characterize the partially purified TPIs from melanoma cell culture media.
Main Methods:
- Culturing human malignant melanoma (Bowes) and nonmalignant (human fetal lung fibroblasts) cells.
- Assaying TPI activity in culture media and intracellular fractions.
- Partial purification of TPIs using Sephadex G-150, papain-Sepharose, and Sephadex G-50 chromatography.
- Molecular weight determination and characterization using SDS-PAGE, heat stability, and pH stability assays.
Main Results:
- Cultured human malignant melanoma cells secreted significantly higher levels of TPI activity compared to nonmalignant cells.
- Two distinct TPIs were identified in melanoma cell culture media, with molecular weights of 56,000 and 9,800–10,800 Da.
- The predominant low-molecular-weight TPI demonstrated high specificity for thiol proteases, was heat-stable, and exhibited unique characteristics distinct from normal human TPIs.
- Cathepsin B was not detected in the culture media of the melanoma cell line.
Conclusions:
- Human malignant melanoma cells release unique thiol protease inhibitors.
- The low-molecular-weight TPI from melanoma cells possesses distinct properties, suggesting a potential role in melanoma progression or evasion.
- Further research into these melanoma-specific TPIs could reveal novel therapeutic targets.